Robert Nelsen

Director AND Co-Founder

Robert Nelsen joined our Board in April 2016. 

Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. He has played a significant role in the creation, early sourcing, financing, and development of more than 100 companies, including over 39 which have reached valuations exceeding $1 billion.

Mr. Nelsen is focused on generating new ideas for disruptive technologies or business models and partnering with founding management teams and entrepreneurs to execute on these visions by advancing novel platform technologies with the overarching goal of improving health care and outcomes. Recent successes include Vir Biotechnology’s COVID-19 antibody therapy, founding National Resilience to transform pharma manufacturing in the US, and initial public offerings for Prime Medicine, Beam Therapeutics and Sana Biotechnology. 

Mr. Nelsen is a director of SANA, National Resilience, Lyell Immunopharma, and serves as Chairman of Hua Medicine, among others. Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. from the University of Puget Sound with majors in economics and biology.